Merck & Co., Inc., a global health care company, discovers, develops, manufactures, and markets medicines, vaccines, biologic therapies, and consumer and animal products. The companys Pharmaceutical segment provides human health pharmaceutical products, such as therapeutic and preventive agents for the treatment of human disorders in the areas of bone, respiratory, immunology, dermatology, cardiovascular diseases, diabetes and obesity, infectious diseases, hypertension and/or heart failure, urology, bronchospasm, neurosciences and ophthalmology, oncology, and womens health; and human health vaccines, including preventative pediatric, adolescent, and adult vaccines against measles, mumps, rubella, and varicella.
Vioxx settlement to cost Merck up to $37M US
Jan 19 - CBC
Sunscreen Makers Face New Test for Cancer-Protection Claims
Jun 14 - Business Week
U.S. Stock Futures Gain on Earnings; Dollar Weakens, Gold Rises
Apr 29, 2011 - Business Week
Merck Profit Tops Analyst Estimates on Higher Drug Sales
Apr 29, 2011 - Business Week
Merck Wins U.S. FDA Panel’s Backing for Hepatitis C Drug
Apr 27, 2011 - Business Week
Merck Increases Stock Repurchase Program by $5 Billion
Apr 27, 2011 - Business Week
Failure of Sanofi, Merck Animal-Health Merger May Trigger Deals
Mar 23, 2011 - Business Week
Merck, Sanofi Abandon Animal Health Deal on Regulatory Snags
Mar 22, 2011 - Business Week
Merck, Sanofi Abandon Animal Health Deal After Regulatory Snags
Mar 22, 2011 - Business Week
Merck, Sanofi Abandon Animal Health Deal After Regulatory Snags
Mar 22, 2011 - Business Week
Merck, Sanofi Abandon Plan to Combine Animal Health Units
Mar 22, 2011 - Business Week
Merck, Sanofi Terminate Animal Health Joint Venture Plan
Mar 22, 2011 - Business Week
Fujifilm to Buy Merck Units to Expand in Biological Drugs Supply
Feb 27, 2011 - Business Week
Fujifilm to Buy Merck Unit for Biotech Supplies, Merck Says
Feb 27, 2011 - Business Week
Most U.S. Stocks Fall as Commodity Producers, Drugmakers Drop
Feb 03, 2011 - Business Week
Before the Bell: Merck & Co., Dow Chemical, jobless claims in focus
Feb 03, 2011 - MarketWatch
Merck 2011 Forecast Misses; Posts Net Loss on Drug
Feb 03, 2011 - Business Week
Merck Blood Thinner Studies Halted in Select Patients
Jan 13, 2011 - Business Week
Merck, Ranbaxy drug development deal called off
Jan 06, 2011 - Business Standard
Merck, Ranbaxy call off research pact
Jan 05, 2011 - Business Standard
By IBTimes
Merck & Co., the second-largest U.S. drugmaker, is projected to report stronger fourth-quarter profit on double-digit growth of key products, an increasing emerging markets presence and further cost reductions. (Jan 31)
MORE TOPICS: CHINA, NYSE, MANUFACTURING, PFIZER, NEW YORK, NEW JERSEY
By IBTimes
Warner Chilcott Plc (WCRX), Roche Holding AG (ROG), Merck & Co. and Novartis AG (NOVN) need to change the labeling of Bisphosphonates, a medicine taken by patients to prevent and cure osteoporosis, the FDA said. (Sep 10)
MORE TOPICS: NEW YORK, BONE FRACTURE, CANCER
By IBTimes
The companies whose shares are moving in pre-market trade on Friday are: CF Industries Holdings, PG&E, Freeport-McMoRan Copper, Merck & Co, TECO Energy, First Solar, eBay, Nvidia, Halliburton and Regions Financial Corp. (Aug 05)
By IBTimes
The companies whose shares are moving in pre-market trade on Wednesday are: Corning, Baker Hughes, Carnival Corp, Boeing, Hess Corp, Merck & Co, GlaxoSmithKline, LDK Solar, FMC Technologies, Rockwell Automation and Johnson & Johnson. (Apr 27, 2011)
MORE TOPICS: NYSE, CARNIVAL, GLAXOSMITHKLINE
By IBTimes
Pharma giant Merck said it discontinued Isentress once daily study in treatment-naïve adult HIV-1 patients after it failed to show non-inferiority to the treatment regimen that included Isentress twice daily. (Nov 29, 2010)
MORE TOPICS: AIDS, NEW JERSEY, INFECTION
By IBTimes
Healthcare giant Merck & Co. Inc. (MRK) reported a 90 percent drop in third quarter profit due to restructuring costs and legal reserve. (Oct 29, 2010)
MORE TOPICS: GLAXOSMITHKLINE, PFIZER, NYSE, NEW JERSEY, ASTHMA, INFECTION
By IBTimes
US pharmaceutical giant Merck & Co. announced, Thursday, it will shed at least 15,000-16,000 jobs and shut down several research sites and manufacturing plants across the world in its efforts to streamline its business operations. (Jul 08, 2010)
MORE TOPICS: NYSE, PORTUGAL, GERMANY, MANUFACTURING, PFIZER, ARGENTINA, MEXICO
By Reuters
Merck & Co will team up with South African drugmaker Adcock Ingram to promote drugs in South Africa, increasing the presence of both companies in Africa's biggest economy. (Jun 24, 2010)
MORE TOPICS: SOUTH AFRICA, GHANA, KENYA
By Reuters
Merck & Co <MRK.N>, which recently acquired U.S. rival Schering-Plough, reported better-than-expected first-quarter earnings, but its 2010 profit forecast barely encompassed Wall Street expectations. (May 04, 2010)
Free Edition
TAKE A TOURStay connected with the IBTimes using your favorite social networks and online news applications:
We value your privacy. Your email address will not be shared.
